Basic Info.
Model NO.
30/50/60/100 tests
Applicable Platform
Clite-160I/ Smart 500h
Temperature
2-8
Transport Package
Foam Box
Specification
30/50/60/100 tests
Trademark
Biochip Langdao
Origin
Tianjin
HS Code
3006300000
Production Capacity
10000/Week
Product Description
Basic Info.
Name: hs-CRP+CRP
Test Time: 15 Min
Temperature: 2-8ºC
Transport Package : Foam Box
Specimen : Serum/Plasma
Production Capacity: 10000/Week
Applicable Device : CLite-160i/SMART 500H
Shelf life : 12 months
Specification: 30/60 tests/box (CLite-160i)
50/100 tests/box (SMART 500H)
Name: hs-CRP+CRP
Test Time: 15 Min
Temperature: 2-8ºC
Transport Package : Foam Box
Specimen : Serum/Plasma
Production Capacity: 10000/Week
Applicable Device : CLite-160i/SMART 500H
Shelf life : 12 months
Specification: 30/60 tests/box (CLite-160i)
50/100 tests/box (SMART 500H)
Total C-reactive proteins include hypersensitive C-reactive protein (hs-CRP) and conventional C-reactive protein (conventional CRP). C-reactive protein (CRP) is an acute phase reaction protein with a structure of positive pentamer, mainly synthesized by the liver. It is a special glycoprotein that appears in human serum in the acute phase of some diseases. It has the ability to activate complement, promote phagocytosis and immune conditioning, has good stability and accuracy, and is a marker of inflammation and tissue damage.
The Clinical Significance
Diagnosis and differentiation of infection: Routine C-reactive protein testing plays an important role in determining the degree of bacterial or viral infection, treatment effectiveness, and prognosis. CRP starts to rise 6-8 hours after bacterial infection occurs, reaches its peak at 24-48 hours, and its content drops sharply after the infection is eliminated. It can return to normal within a week.
Diagnosis and differentiation of infection: Routine C-reactive protein testing plays an important role in determining the degree of bacterial or viral infection, treatment effectiveness, and prognosis. CRP starts to rise 6-8 hours after bacterial infection occurs, reaches its peak at 24-48 hours, and its content drops sharply after the infection is eliminated. It can return to normal within a week.
Double antibody sandwich method was used in the kit. The detection principle is: the sample to be tested, R1 reagent, R2 reagent and M reagent are mixed for incubation, and the fluorescein (FITC) labeled CRP antibody 1 in R1 reagent and the alkaline phosphatase (ALP) labeled CRP antibody 2 in R2 reagent are combined with the CRP antigen molecules in the sample to form an immune complex. The immune complex is further captured by anti-FITC antibodies coupled to the surface of the magnetic particle and adsorbed to the surface of the magnetic particle. After washing, the unbound material was removed and the luminescent substrate was added, ALP catalyzed the luminescence of the substrate, and the relative luminescence intensity (RLU) was determined.
| Product Parameter | |
| Specimen | Serum/Plasma |
| Detection range | 0.1~200.0 (mg/L) |
| Precision | CV<5% |
| Test Time | 15 Min |
| LOD | 0.1mg/L |
Applicable Device
Automated Chemiluminescence Immunoassay Analyzer CLite-160i
Company Profile
Biochip Langdao (Tianjin)Medical Technology Ltd. is a R&D based biotechnology company, specializing in the research and production of in vitro diagnostics, medical devices, and medical products for public health. "Biochip Langdao" has been awarded National High-tech Enterprise by the Chinese government, products are widely used in hospital laboratories, independent medical laboratories, physical examination centers, clinics, and pharmacies. Its holding company Beijing Promed Medical Technology Co.,Ltd. is a public company listed at BSE (Ticker: 835373).
"Biochip Langdao" owns Magnetic microparticle chemiluminescence technology, and has developed a patented strip-based fully automatic chemiluminescence immunoassay analyzer: CLite-160i analyzer. 12 testing reagents have been successfully developed on CLite-160i analyzer including 5 myocardial biomarkers, 4 inflammatory biomarkers, and 3 gastritis markers, all of which have obtained NMPA and CE certificate. More testing reagents are in R&D pipeline and are expected to launch by March 31, 2024, including thyroid hormones, sex hormones, tumor markers, brain injury, acute renal disfunction.
In addition, the company has established production lines for sprays, powders, gel, and granules medical products. These include medical equipment, disinfectant, personal care products. Among them, "Well-Fit" Anti-allergy nasal barrier gel is unique in this field which has a special formula and unique dosage form, indicated to use for prevention and treatment of allergic rhinitis and prevention of flu.
The company owns the registered trademark "Biochip Langdao" covering fields such as in vitro diagnostics, medical devices, and biological preparations, and the registered trademark "Well-Fit" covering fields such as oral and nasal medication, disinfectant, and medical dressings.
"Biochip Langdao" adheres to its business philosophy of "Developing by Innovation, Integrity as Cornerstone", keeps investing for more advanced technology and improving products quality.
Office
Lab
Biochip Langdao (Tianjin)Medical Technology Ltd. is a R&D based biotechnology company, specializing in the research and production of in vitro diagnostics, medical devices, and medical products for public health. "Biochip Langdao" has been awarded National High-tech Enterprise by the Chinese government, products are widely used in hospital laboratories, independent medical laboratories, physical examination centers, clinics, and pharmacies. Its holding company Beijing Promed Medical Technology Co.,Ltd. is a public company listed at BSE (Ticker: 835373)."Biochip Langdao" owns Magnetic microparticle chemiluminescence technology, and has developed a patented strip-based fully automatic chemiluminescence immunoassay analyzer: CLite-160i analyzer. 12 testing reagents have been successfully developed on CLite-160i analyzer including 5 myocardial biomarkers, 4 inflammatory biomarkers, and 3 gastritis markers, all of which have obtained NMPA and CE certificate. More testing reagents are in R&D pipeline and are expected to launch by March 31, 2024, including thyroid hormones, sex hormones, tumor markers, brain injury, acute renal disfunction.
In addition, the company has established production lines for sprays, powders, gel, and granules medical products. These include medical equipment, disinfectant, personal care products. Among them, "Well-Fit" Anti-allergy nasal barrier gel is unique in this field which has a special formula and unique dosage form, indicated to use for prevention and treatment of allergic rhinitis and prevention of flu.
The company owns the registered trademark "Biochip Langdao" covering fields such as in vitro diagnostics, medical devices, and biological preparations, and the registered trademark "Well-Fit" covering fields such as oral and nasal medication, disinfectant, and medical dressings.
"Biochip Langdao" adheres to its business philosophy of "Developing by Innovation, Integrity as Cornerstone", keeps investing for more advanced technology and improving products quality.
Office
Workshop
Logistics 
1.How to ship the product?
The shipping way normally depends on your quantity,total CBM and weight.
We have our own shipping company to provide best shipping cost and efficient way.
2. Do you provide samples? Is it free or extra?
Yes, if you buy equipment we could offer a sample test for free charge but do not pay the cost of freight.
3.what can you buy from us?
Chemiluminescence Immunoassay Analyzer,In Vitro Diagnostic Reagent ,Healthy Care etc.
4. What is your warranty?
For most products the warranty is for 12 months, for some products we provide 18 months warranty.
5.Do you have the CE certificate ?
Yes, most of our products have the CE certificate.